Danish Study Finds No Increased CV Risk With Azithromycin In General Population
A large observational study found no increased risk for cardiovascular events associated with azithromycin (Zithromax, Pfizer) in a general population of young and middle-age adults. In a paper published in the New England Journal of Medicine, Danish investigators report the results of a large national observational study comparing people who took azithromycin with matched controls who took no antibiotics and with matched controls who took penicillin V for similar indications. Although there was a significant increase in the risk of death from cardiovascular causes in people taking azithromycin compared with people taking no antibiotics (RR More…
Source: CardioBrief - Category: Cardiology Authors: Larry Husten Tags: People, Places & Events Policy & Ethics Prevention, Epidemiology & Outcomes antibiotics azithromycin FDA Pfizer Zithromax Source Type: blogs
More News: Azithromycin | Cardiology | Cardiovascular | Epidemiology | Heart | Medical Ethics | Penicillin | Pfizer | Study | Zithromax